Our medical device Intuity® Spray received an award at the Pharmapack 2021 exhibition in the exhibitor - administration mode category.

At Pharmapack in Paris, next week, discover our innovations for drug delivery with new medical devices and components to facilitate treatment and patient compliance.

EVEON has developed Ad-Mist, an airless spray nozzle that can be used to produce fine droplets in the form of a mist. This spray nozzle can be integrated into dedicated automatic medical devices to facilitate the administration of treatments by the patient, or simply connected directly to a syringe.

Article OnDrugDelivery about the gap between patient safety and HealthCareWorkers for product preparation. And How safe and automatic, such as EVEON devices, can improve drug preparationCheckout our last article for multidose vials?

EVEON has signed a collaboration agreement with BEPATIENT to produce patient-centric digital solutions that serve both clinical research and digital therapeutics applications.

EVEON is proposing to automate and deliver multidose drugs from a vial, as well as vaccines used in the context of the Covid-19 pandemic.

EVEON carried out many innovative projects in 2020. This new year is also promising for the company driven forward by this positive dynamics.

EVEON contributes to studies about feasibility of intratumoral delivery to induced glioblastoma, in a large animal model. EVEON developed the preclinical injection system for this project. Work on this subject has been published in the journal Plos One.

The project KinCellS, supported by the Auvergne Rhone Alpes region, as part of the call for R&D booster projects, was launched on September 9th, 2020, with the consortium members : Nanobiose, project leader, EVEON and the SyMMES laboratory.

Article OnDrugDelivery about the results of work carried out in joint efforts by EVEON and LMGP in the field of protein adsorption and aggregation, and how the results of this work have led to improvements in the design of EVEON’s proprietary micropump.